Beta Bionics (BBNX) Interest Coverage Ratio: History & Chart

Beta Bionics, Inc.(BBNX)

Medical - Devices · Irvine, CA

$18.63-0.32 (-1.69%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Beta Bionics, Inc.

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.

Irvine, CA

422 employees

www.betabionics.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Sean T. Saint

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Beta Bionics, Inc. (BBNX)	$838.16M	N/A	N/A	N/A	N/A
Pacific Biosciences of California, Inc. (PACB)vs ›	$838.62M	-80.18x	N/A	N/A	N/A
Monte Rosa Therapeutics, Inc. (GLUE)vs ›	$833.81M	N/A	N/A	N/A	N/A
SpyGlass Pharma, Inc. Common Stock (SGP)vs ›	$828.48M	N/A	N/A	N/A	N/A
SL Science Holding Ltd (SLBT)vs ›	$852.35M	N/A	N/A	N/A	N/A
Rigel Pharmaceuticals, Inc. (RIGL)vs ›	$853.13M	17.14x	10.10x	10.10x	10.10x
Alumis Inc. (ALMS)vs ›	$855.38M	N/A	N/A	N/A	N/A
QuidelOrtho Corporation (QDEL)vs ›	$857.16M	-5.18x	6.05x	536.48x	359.36x
Ardelyx, Inc. (ARDX)vs ›	$817.67M	-1.44x	N/A	N/A	N/A
Jade Biosciences, Inc. (JBIO)vs ›	$816.13M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Beta Bionics, Inc. (BBNX)

$838.16M

N/A

Pacific Biosciences of California, Inc. (PACB)vs ›

$838.62M

-80.18x

N/A

Monte Rosa Therapeutics, Inc. (GLUE)vs ›